📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors. (2017)

First Author: Arce Vargas F
Attributed to:  MICA: Immunotherapy for oral cancer prevention and treatment funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.immuni.2017.03.013

PubMed Identifier: 28410988

Publication URI: http://europepmc.org/abstract/MED/28410988

Type: Journal Article/Review

Volume: 46

Parent Publication: Immunity

Issue: 4

ISSN: 1074-7613